Levofloksacin Sandoz (Levofloxacin)

Levofloxacin inhibits bacterial DNA gyrase (topoisomerase II) and topoisomerase IV, enzymes required for DNA supercoiling and replication. By blocking these targets, the drug prevents bacterial DNA synthesis and transcription, leading to rapid bacterial cell death across a broad spectrum of Gram‑negative and Gram‑positive organisms.

The specific dose and duration of levofloxacin therapy are determined by the prescribing clinician based on the infection type, severity, patient renal function, and other clinical factors. No standard dosing regimen is provided here; the prescriber sets the appropriate regimen.

Safety data for levofloxacin during pregnancy and lactation are limited. It should be used only when the potential benefit to the mother outweighs any possible risk to the fetus or infant. Women who are pregnant, planning pregnancy, or breastfeeding should discuss alternatives with their healthcare provider.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, and will request verification of trade or institutional credentials. The sales team then replies with pricing, availability, shipping details (including cold‑chain if needed) and any required import documentation.

Levofloxacin is the L‑isomer of ofloxacin and generally offers higher potency, better tissue penetration, and once‑daily dosing for many infections compared with older agents such as ciprofloxacin. It retains activity against many Gram‑negative pathogens while also covering typical Gram‑positive organisms, making it a broad‑spectrum option in the fluoroquinolone class.

Levofloksacin Sandoz should be stored below 25 °C (77 °F) in its original packaging, protected from moisture and light. Do not freeze the product. Follow any additional handling instructions provided by the supplier to maintain sterility and potency.

The medication is supplied as an injectable solution for intravenous infusion. Administration is performed by a qualified healthcare professional, typically over a period of 30 minutes to 1 hour, depending on the prescribed dose and clinical protocol.

Serious adverse events include tendon rupture or tendinitis, especially in older adults or those on corticosteroids; QT‑interval prolongation leading to potentially fatal arrhythmias; severe hypersensitivity reactions such as anaphylaxis or Stevens‑Johnson syndrome; and Clostridioides difficile‑associated colitis, which can be life‑threatening.

Levofloksacin Sandoz is contraindicated in patients with a known hypersensitivity to levofloxacin or other fluoroquinolones. It should be avoided in individuals with a history of tendon disorders related to fluoroquinolone use, those with prolonged QT interval, and patients receiving concomitant drugs that significantly prolong QT. Caution is also advised for pediatric patients, pregnant or lactating women, and those with severe renal impairment unless dose adjustments are made.